Heres what that looks like in practice: MC1R Activation: Leads to very strong eumelanin production, often resulting in a deeper, faster tan compared to MT1 at similar research doses
Breeds that are prone to cataracts or other retinal conditions will also benefit
Their work underscores that the problem is biological, not behavioral
Unlike broad anti-inflammatory drugs, senolytics work by exploiting the unique survival dependencies of senescent cells, targeting pro-survival pathways such as BCL-2/BCL-xL, PI3K/AKT, and HSP90 that senescent cells upregulate to resist apoptosis
14,15 Because of the results of these landmark clinical trials, evidence-based treatment guidelines now recommend the GLP-1/GIP agonists as an important second-line treatment for uncomplicated type 2 diabetics who fail to meet hemoglobin A1c targets on popular first-line agents such as metformin